<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Herpes simplex virus type 2 and cancer : a medical geography approach</dc:title>
  <dc:creator>Thomas, F.</dc:creator>
  <dc:creator>/Elguero, Eric</dc:creator>
  <dc:creator>Brodeur, J.</dc:creator>
  <dc:creator>Le Goff, J.</dc:creator>
  <dc:creator>/Miss&#xE9;, Doroth&#xE9;e</dc:creator>
  <dc:subject>Genital herpes</dc:subject>
  <dc:subject>Medical geography</dc:subject>
  <dc:subject>Prostate cancer</dc:subject>
  <dc:subject>Melanoma</dc:subject>
  <dc:description>Herpes simplex virus type-2 (HSV-2) has been identified as a possible aetiological agent of cancer in humans, especially prostate cancer, but results remain controversial. Here, we have addressed this question using a medical geography approach based on the national incidence of various cancers and seroprevalence of HSV-2 in 64 countries worldwide. We corrected reports of cancer incidence for national gross domestic product (GDP) because living in a wealthy nation likely increases the probability of having a cancer detected. Data were also corrected for latitude and diet. Our analysis not only confirms that prostate cancer and HSV-2 seroprevalence are positively associated, but it also reveals the existence of a positive relationship between HSV-2 and melanoma incidence in both men and women. These results, though correlational, suggest that HSV-2 should continue to be investigated as a possible oncogenic pathogen of humans.</dc:description>
  <dc:date>2011</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010053762</dc:identifier>
  <dc:identifier>fdi:010053762</dc:identifier>
  <dc:identifier>Thomas F., Elguero Eric, Brodeur J., Le Goff J., Miss&#xE9; Doroth&#xE9;e. Herpes simplex virus type 2 and cancer : a medical geography approach. 2011, 11 (6), 1239-1242</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
